Showing results (311-320 of 414) with videos related to
Sort By:
Pageof 42
Journal of Surgical Oncology|January 1, 1977
Carcinoembryonic antigen in osteosarcomaE P Cortes, T M Chu, J J Wang, et al.Journal of Surgical Oncology|April 1, 1983
The effects of cholestyramine, colestipol, and ADR-132 on the rat prostate and dunning R-3327 adenocarcinomaW J Brown, J P Karr, M McGarry, et al.The Prostate|March 22, 2000
Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patientsG P Murphy, B A Tjoa, S J Simmons, et al.Cancer|October 1, 1996
The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer SocietyN E Fleshner, H W Herr, A K Stewart, et al.Urology|February 1, 1987
Zoladex (ICI 118,630): clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinomaG P Murphy, J M Greco, J L Chin, et al.Surgery, Gynecology & Obstetrics|April 1, 1984
Management of cutaneous melanoma in the United StatesC M Balch, C Karakousis, C Mettlin, et al.Cancer Chemotherapy Reports|January 1, 1975
Tumor antigen and acid phosphatase isoenzyme in prostatic cancerT M Chu, A Bhargava, E A Barnard, et al.Investigative Urology|November 1, 1980
Quantitative counterimmunoelectrophoresis assay for prostatic acid phosphataseC S Killian, F P Vargas, C L Lee, et al.PDA Journal of Pharmaceutical Science and Technology|January 1, 1996
Application of total organic carbon analysis to cleaning validationK M Jenkins, A J Vanderwielen, J A Armstrong, et al.Cancer Treatment Reports|March 1, 1977
Some new approaches to potential test systems for drugs against prostatic cancerA A Sandberg, J Müntzing, N Kadohama, et al.Pageof 42